Correction: etodolac - a new NSAID (February 9, p.12)
The article incorrectly described the trial by Jacob et al (ref 8) as a 2-week trial in which positive faecal occult blood tests were more frequent with etodolac than sulindac. In fact this trial lasted 12 weeks and more positive tests occurred on sulindac.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.